Studies link gut dysbiosis to pancreatic cancer, offering pathways for early detection

The gut microbiome’s impact on pancreatic cancer highlights potential for early screening and fecal microbiota transplantation in improving treatment efficacy.

Comparing perioperative differences: Sleeve gastrectomy vs. Roux-en-Y gastric bypass

Study compares laparoscopic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in obese patients, finding both procedures have low, comparable perioperative risks and complications, challenging

February 2, 2024

Intellia plays down concerns about accidental germline transmission in CRISPR trial

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and

August 21, 2023

Merck inks deal with Unnatural Products; CG Oncology’s upsized IPO; Locus gets $24M from BARDA

Plus, news about Outlook Therapeutics and Adicet Bio: Merck and Unnatural Products collaborate: Per the deal, Merck will make an undisclosed upfront payment to the

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.